Navigation Links
Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Date:4/26/2012

ofile.

About Hypertriglyceridemia

Hypertriglyceridemia refers to a condition in which patients have high blood levels of triglycerides and is associated with increased risk of heart disease. It is one component of a range of lipid disorders collectively referred to as dyslipidemia. The overall dyslipidemia population in the U.S. is believed to be in excess of 100 million, with approximately 35 million of those diagnosed with hypertriglyceridemia (triglycerides greater than 200mg/dL) and an estimated 5 million with very high triglyceride levels (triglycerides greater than 500mg/dL). Very high triglycerides are associated with an increased risk of pancreatitis. Regulatory approval for the treatment of very high triglycerides is based on a significant reduction in the serum triglyceride levels.

About Omthera Pharmaceuticals, Inc.

Founded in 2008, Omthera Pharmaceuticals, Inc. is a privately held, specialty pharmaceutical company focusing its efforts on the clinical development of new therapies for dyslipidemia.  Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.  Omthera holds worldwide rights to Epanova under a license from Chrysalis Pharma AG, a privately held Swiss company that is the owner of the product. For more information, please visit www.omthera.com

Omthera Contact:

Christian Schade

Chief Financial Officer

Omthera Pharmaceuticals

908-741-6402

CSchade@Omthera.com

Omthera Media Relations:

Eric Goldman

Vice President Public Relations

Rx Communications Group, LLC

917-322-2563

<
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Omthera Pharmaceuticals, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference and Citi 2012 Global Healthcare Conference
2. Omthera Pharmaceuticals Announces Positive Long Term Bioavailability Data Comparing Epanova™ to Lovaza®
3. Omthera Pharmaceuticals, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference
4. Omthera Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference
5. Timothy J. Maines Joins Omthera Pharmaceuticals as Vice President of Quality
6. Omthera Pharmaceuticals, Inc. to Present at the Rodman and Renshaw 13th Annual Healthcare Conference
7. Omthera Pharmaceuticals, Inc. Initiates Phase III ESPRIT Trial of Add-on Epanova™ to Statin Therapy in Patients with Hypertriglyceridemia
8. Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
9. Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. as Chief Operating Officer
10. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
11. Omthera Pharmaceuticals, Inc. to Present at the BIO Windhover/Pharmaceutical Strategic Outlook 2011 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Calif. , May 23, 2013 More ... cancer may not benefit from chemotherapy and still have ... the launch of one of the largest sources of ... new website and interactive Facebook page provide recently diagnosed ... they can safely avoid chemotherapy. "We anticipate ...
(Date:5/23/2013)... Calif. , May 23, 2013 Anthem ... program that would have required them to obtain their ... by Consumer Watchdog and Whatley Kallas LLC.  ... Superior Court, alleged that Blue Cross,s mandatory mail order ... threatening their health and privacy. "This settlement ...
(Date:5/23/2013)... Texas , May 23, 2013  Texas, premier ... to deliver doctors the survival tools they need to ... compete in today,s health care marketplace. "I ... will save local practices," said Stephen L. ... Association (TMA). " Texas doctors are ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... Qmed .com , the world,s only 100% ... engine, and central industry resource, today announced a ... ground-breaking detailed reports of industry-related adverse events, ... http://photos.prnewswire.com/prnh/20120423/LA91769LOGO )   (Logo: http://photos.prnewswire.com/prnh/20101214/LA16070LOGO ...
... BEACH, Fla., April 23, 2012  SurgLine International, Inc. ... International, Inc. ("SGLN") and SurgLine, Inc. ("SurgLine") stated ... SurgLine has formed SurgLine MDC Holdings, LLC. ("SMDC"), ... owned subsidiary.  SMDC will be forming  joint-venture opportunities ...
Cached Medicine Technology:Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events 2Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events 3Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events 4SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies 2
(Date:5/23/2013)... May 23, 2013 Live ... contemporary services, provides the best business lead solution ... Its Call center Management solution features Free Web ... Call Limitation, Do-Not-Call Maintenance and "Automatic Transfer Retry". ... comprehensive campaign delivery and management system. , Its ...
(Date:5/23/2013)... drug about to be tested in a clinical trial ... treatment for Alzheimer,s disease has failed to work with ... patients, according to results of a study by University ... of neuroscience affiliated with the Evelyn F. and William ... emphasized the importance of verifying promising research results before ...
(Date:5/23/2013)... poor prognosis, with limited treatment options. In some ... it,s supposed to. New research from Western University explains ... identifies a mechanism to rectify that. ... team at Western,s Schulich School of Medicine & Dentistry, ... the death of cancer cells by binding to and ...
(Date:5/23/2013)... New York, New York (PRWEB) May 23, 2013 ... products manufactured by C.R. Bard, Inc., continue to move ... District Court, Southern District of West Virginia, Bernstein Liebhard ... 17th, the Court denied a request by C.R. Bard ... claimed would reveal trade secrets and other confidential, proprietary ...
(Date:5/23/2013)... 2013 Former United States Vice President ... Acadian 's annual Paramedic Luncheon. , In front ... Cheney praised Acadian's medics, saying, "I am delighted to ... awarding the Paramedic of the Year Award. I think ... lot of competition within a company like this because ...
Breaking Medicine News(10 mins):Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2
... which is ill-equipped to cope, say experts. The amount of ... and rising, suggests health data. ,India has a population of ... developing diabetes later in life, and are certainly more vulnerable ... coronary heart disease. ,Part of the blame falls ...
... is bad for health. ,It seems that smokers have a ... heart disease in their blood. The discovery could help explain ... attacks than non-smokers. ,Paraoxonase is a enzyme which ... blood vessels. A team of Swiss researchers examined 367 people ...
... weapons go, anthrax is nowhere as terrifying as several others, ... University. Smallpox would be a lot worse. The government now ... Experiments are getting underway to see whether it can be ... still be effective. // ,“Anthrax is not ...
... less than 1mm in diameter, presents a new opportunity for ... Hollywood film technicians who worked alongside Dr Nicolas Beechey-Newham and ... at Guy’s Hospital in London to produce the “micro-camera”. ... the opening in a nipple – is able to view ...
... efficacy of a malaria drug are being questioned by ... be withdrawn. Manufacturer GlaxoSmithKline markets the anti-malarial drug Malarone ... at preventing the aggressive falciparum strain of malaria, but ... the Consumers’ Association – says the evidence for this ...
... be more likely to create illness than the weapons themselves, ... result of panic caused by the news of anthrax attacks. ... the UK, US and Australia predicted that while bioweapons themselves ... is having a devastating effect. ,Already, there are ...
Cached Medicine News:Health News:Diabetes on the rise, 2Health News:All the more bad, 2